HC Wainwright & Co. Reiterates Buy on Compass Pathways, Maintains $120 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Compass Pathways (NASDAQ:CMPS) and maintained a price target of $120.
August 04, 2023 | 4:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Compass Pathways (NASDAQ:CMPS) has been reiterated with a 'Buy' rating by HC Wainwright & Co. The price target remains at $120.
The reiteration of a 'Buy' rating and a maintained price target of $120 by HC Wainwright & Co. indicates a positive outlook for Compass Pathways. This could potentially lead to an increase in investor confidence and a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100